Cardiovascular Device Market- Global Industry Analysis and Forecast (2022-2029)

Cardiovascular Device Market size is expected to grow at 6.8% throughout the forecast period, reaching nearly US$ 91.53 Bn by 2029.

Introduction and Market Dynamics:

Cardiovascular disorder contains conditions that narrow or block blood vessels (coronary heart disease). This can cause a heart attack, angina, and a few strokes. The report study has analyzed revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers and market disrupters in the report and same is reflected in our analysis. By Device, Electrocardiography (ECG) segment was valued at USD xx Mn. in 2021 and is expected to reach USD xx Mn. by 2029 at a CAGR of xx% during the forecast period. In North America the cardiovascular devices market is majorly stimulated by the changes or the sifting in the trend of the technology that permits the players to develop modern devices. The many players are getting several approvals for the cardiovascular devices for example, Medtronic, Abbott and W. L. Gore & Associates has received approvals for products. Cardiovascular Device MarketTo know about the Research Methodology :- Request Free Sample Report The market for these cardiovascular devices is impelled by way of the excessive incidence of the target disorder because of unhealthy living habits such as smoking, consumption of alcohol, and hypertension, together with a growing geriatric populace. The changing life and upward thrust inside the geriatric population is identified as primary reason behind the threat of cardiovascular problems. Cardiovascular sicknesses (CVDs) are the number one cause of death globally, taking a predicted 17.9 million lives every year. Proper medical transformations together with suitable value-powerful treatments supported with insurance and reimbursements have shaped the growth curve. Also, planned acquisitions and mergers together with the number one product launches have fostered the market. Heart diseases, together with coronary heart disease, heart attack, congestive coronary heart failure, and congenital coronary heart disease, are the main reason of death for women and men within the U.S. The novel product helps in augmenting higher results for health and lives a better existence. The market is associated with numerous marketplace leaders who are conducting various developmental activities for cardiovascular devices. For example, the mobile cardiac telemetry (MCT) system is a revolutionary product this is helping cardiac patients to monitor their heart condition. The mobile cardiac telemetry is a small sensor and monitor that patients put on in their daily life. However, adverse trade relations, excessive value of device maintenance and shortage of professional personnel have become prime source of limitations to the market.

Cardiovascular Device Market Segment Analysis

By Device, Electrocardiography ECG holds at least 40% of the share, and this will be credited to the improved capacities of the new generation Electrocardiograms. On the diagnostic and tracking front, a brand new technology of portable and compact ECG is impelling its greater adoption, in particular inside the home healthcare phase. There has been an upsurge in the occurrence of cardiovascular diseases (CVD), wherein a long-term ECG monitoring is vital and with the introduction of wireless ECG, doctors can monitor and diagnose the patient remotely on time, which further boost the market growth. Besides, growing cardiovascular illnesses, consisting of arrhythmias, stroke, and excessive blood pressure, are growing the demand for cardiovascular devices; in consort with mounting cognizance and demand for minimally invasive surgeries are also anticipated to thrust the cardiovascular device market. In 2021, coronary heart disease held the most important market share of 41.9% of the cardiovascular devices market, by application. The coronary heart disease segment is expected to rule its market share in 2029 because of the growing incidence of the disease.

Cardiovascular Device Market Regional analysis

The North America cardiovascular device market was valued at US$ xx million in 2021 and is expected to reach a value of US$ xx million by 2029, with a CAGR of xx% during the forecast period. The increase of the cardiovascular devices market is mainly accredited to the growing developments for cardiovascular devices and the up surging aged populace. On the contradictory hand, mounting medical tourism in Mexico is probably to have a fantastic impact on the growth of the North American cardiovascular devices market in the upcoming years. The cardiovascular devices market is majorly promoted by the changes or the sifting in the trend of the technology that permits the players to develop modern devices. The market is associated with numerous market leaders that are carrying out numerous developmental activities for cardiovascular devices. According to the American College of Cardiology, cardiovascular disorder (CVD) accounted for 800,000 deaths in the United States in 2021 alone. The Asia Pacific is anticipated to see the fastest growth during the forecast period with Japan expected leading the general Asia Pacific market, followed by China. China is predicted to have the largest geriatric population globally with the highest obesity problem rates as a result of inactive life and bad dietary habits. These factors are expected to raise the superiority of cardiac diseases in this country, therefore definitely impacting the growth of the Asia Pacific market. The mounting nations are substantially growing their healthcare centers and offerings and are directing towards technological improvements. For example, the structural heart is on the initial stage of the activities improvement in regions such as the Asia Pacific and the Middle East and Africa.

Cardiovascular Device Market Key Development

• In August 2021, Boston Scientific Corporation acquired Claret Medical Inc. to take advantage of the product range of the acquired company which produces devices protect patients from the threat of being affected by stroke after valve replacement surgeries. • In June 2021, LivaNova plc received an approval for advanced technological developments in surgical options for the treatment of the aortic valve diseases from the Japanese Minister of Health, Labor and Welfare. The objective of the report is to present a comprehensive analysis of the Global Cardiovascular Device Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Cardiovascular Device Market dynamics, structure by analysing the market segments and projects the Global Cardiovascular Device Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Cardiovascular Device Market make the report investor’s guide.

Cardiovascular Device Market Scope: Inquire before buying

Global Cardiovascular Device Market
Report Coverage Details
Base Year: 2021 Forecast Period: 2022-2029
Historical Data: 2017 to 2021 Market Size in 2021: US $ 54.07 Bn.
Forecast Period 2022 to 2029 CAGR: 6.8% Market Size in 2029: US $ 91.53 Bn.
Segments Covered: by Device • Electrocardiography (ECG) • Stent • Defibrillator • Cardiac Catheter • Guide wire • Event Monitor • Heart Valve • Pacemaker • Others
by Application • Stroke • Cerebrovascular Heart Disease • Coronary Heart Disease • Sudden Cardiac Arrest • Others
by End-User • Cardiac Centers • Hospitals • Ambulatory Surgical Centers

Cardiovascular Device Market, By Regions

• North America • Europe • Asia-Pacific • South America • Middle East and Africa (MEA)

Cardiovascular Device Market Key Players

• Siemens AG • BD • B. Braun Melsungen AG • Edwards Lifesciences Corporation • Medtronic • Biosense Webster, Inc (Johnson and Johnson) • General Electric Company • Koninklijke Philips N.V • Boston Scientific Corporation • Abbott • Jarvik Heart • Maquet Cardiovascular • Merit Medical Systems • On-X Life Technologies • Orbusneich • St. Jude Medical • Sorin Group • Spectranetics • Sunshine Heart • Syncardia Systems • Thoratec • Volcano

Frequently Asked Questions:

1. Which region has the largest share in Global Cardiovascular Device Market? Ans: North America region held the highest share in 2021. 2. What is the growth rate of Global Cardiovascular Device Market? Ans: The Global Cardiovascular Device Market is expected to grow at a CAGR of 6.8% during forecast period 2022-2029. 3. What is scope of the Global Cardiovascular Device market report? Ans: Global Cardiovascular Device Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Cardiovascular Device market? Ans: The important key players in the Global Cardiovascular Device Market are – Siemens AG, BD, B. Braun Melsungen AG, Edwards Lifesciences Corporation, Medtronic, Biosense Webster, Inc (Johnson and Johnson), General Electric Company, Koninklijke Philips N.V, Boston Scientific Corporation, Abbott, Jarvik Heart, Maquet Cardiovascular, Merit Medical Systems, On-X Life Technologies, Orbusneich, St. Jude Medical, Sorin Group, and Spectranetics 5. What is the study period of this market? Ans: The Global Cardiovascular Device Market is studied from 2021 to 2029.
Global Cardiovascular Device Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Cardiovascular Device Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Cardiovascular Device Market Analysis and Forecast 6.1. Global Cardiovascular Device Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Cardiovascular Device Market Analysis and Forecast, By Device 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Cardiovascular Device Market Value Share Analysis, By Device 7.4. Global Cardiovascular Device Market Size (US$ Bn) Forecast, By Device 7.5. Global Cardiovascular Device Market Analysis, By Device 7.6. Global Cardiovascular Device Market Attractiveness Analysis, By Device 8. Global Cardiovascular Device Market Analysis and Forecast, By End User 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Cardiovascular Device Market Value Share Analysis, By End User 8.4. Global Cardiovascular Device Market Size (US$ Bn) Forecast, By End User 8.5. Global Cardiovascular Device Market Analysis, By End User 8.6. Global Cardiovascular Device Market Attractiveness Analysis, By End User 9. Global Cardiovascular Device Market Analysis and Forecast, By Application 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Cardiovascular Device Market Value Share Analysis, By Application 9.4. Global Cardiovascular Device Market Size (US$ Bn) Forecast, By Application 9.5. Global Cardiovascular Device Market Analysis, By Application 9.6. Global Cardiovascular Device Market Attractiveness Analysis, By Application 10. Global Cardiovascular Device Market Analysis, by Region 10.1. Global Cardiovascular Device Market Value Share Analysis, by Region 10.2. Global Cardiovascular Device Market Size (US$ Bn) Forecast, by Region 10.3. Global Cardiovascular Device Market Attractiveness Analysis, by Region 11. North America Cardiovascular Device Market Analysis 11.1. Key Findings 11.2. North America Cardiovascular Device Market Overview 11.3. North America Cardiovascular Device Market Value Share Analysis, By Device 11.4. North America Cardiovascular Device Market Forecast, By Device 11.4.1. Electrocardiography (ECG) 11.4.2. Stent 11.4.3. Defibrillator 11.4.4. Cardiac Catheter 11.4.5. Guide wire 11.4.6. Event Monitor 11.4.7. Heart Valve 11.4.8. Pacemaker 11.4.9. Others 11.5. North America Cardiovascular Device Market Value Share Analysis, By End User 11.6. North America Cardiovascular Device Market Forecast, By End User 11.6.1. Cardiac Centers 11.6.2. Hospitals 11.6.3. Ambulatory Surgical Centers 11.7. North America Cardiovascular Device Market Value Share Analysis, By Application 11.8. North America Cardiovascular Device Market Forecast, By Application 11.8.1. Stroke 11.8.2. Cerebrovascular Heart Disease 11.8.3. Coronary Heart Disease 11.8.4. Sudden Cardiac Arrest 11.8.5. Others 11.9. North America Cardiovascular Device Market Value Share Analysis, by Country 11.10. North America Cardiovascular Device Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Cardiovascular Device Market Analysis, by Country 11.12. U.S. Cardiovascular Device Market Forecast, By Device 11.12.1. Electrocardiography (ECG) 11.12.2. Stent 11.12.3. Defibrillator 11.12.4. Cardiac Catheter 11.12.5. Guide wire 11.12.6. Event Monitor 11.12.7. Heart Valve 11.12.8. Pacemaker 11.12.9. Others 11.13. U.S. Cardiovascular Device Market Forecast, By End User 11.13.1. Cardiac Centers 11.13.2. Hospitals 11.13.3. Ambulatory Surgical Centers 11.14. U.S. Cardiovascular Device Market Forecast, By Application 11.14.1. Stroke 11.14.2. Cerebrovascular Heart Disease 11.14.3. Coronary Heart Disease 11.14.4. Sudden Cardiac Arrest 11.14.5. Others 11.15. Canada Cardiovascular Device Market Forecast, By Device 11.15.1. Electrocardiography (ECG) 11.15.2. Stent 11.15.3. Defibrillator 11.15.4. Cardiac Catheter 11.15.5. Guide wire 11.15.6. Event Monitor 11.15.7. Heart Valve 11.15.8. Pacemaker 11.15.9. Others 11.16. Canada Cardiovascular Device Market Forecast, By End User 11.16.1. Cardiac Centers 11.16.2. Hospitals 11.16.3. Ambulatory Surgical Centers 11.17. Canada Cardiovascular Device Market Forecast, By Application 11.17.1. Stroke 11.17.2. Cerebrovascular Heart Disease 11.17.3. Coronary Heart Disease 11.17.4. Sudden Cardiac Arrest 11.17.5. Others 11.18. North America Cardiovascular Device Market Attractiveness Analysis 11.18.1. By Device 11.18.2. By End User 11.18.3. By Application 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe Cardiovascular Device Market Analysis 12.1. Key Findings 12.2. Europe Cardiovascular Device Market Overview 12.3. Europe Cardiovascular Device Market Value Share Analysis, By Device 12.4. Europe Cardiovascular Device Market Forecast, By Device 12.4.1. Electrocardiography (ECG) 12.4.2. Stent 12.4.3. Defibrillator 12.4.4. Cardiac Catheter 12.4.5. Guide wire 12.4.6. Event Monitor 12.4.7. Heart Valve 12.4.8. Pacemaker 12.4.9. Others 12.5. Europe Cardiovascular Device Market Value Share Analysis, By End User 12.6. Europe Cardiovascular Device Market Forecast, By End User 12.6.1. Cardiac Centers 12.6.2. Hospitals 12.6.3. Ambulatory Surgical Centers 12.7. Europe Cardiovascular Device Market Value Share Analysis, By Application 12.8. Europe Cardiovascular Device Market Forecast, By Application 12.8.1. Stroke 12.8.2. Cerebrovascular Heart Disease 12.8.3. Coronary Heart Disease 12.8.4. Sudden Cardiac Arrest 12.8.5. Others 12.9. Europe Cardiovascular Device Market Value Share Analysis, by Country 12.10. Europe Cardiovascular Device Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Cardiovascular Device Market Analysis, by Country 12.12. Germany Cardiovascular Device Market Forecast, By Device 12.12.1. Electrocardiography (ECG) 12.12.2. Stent 12.12.3. Defibrillator 12.12.4. Cardiac Catheter 12.12.5. Guide wire 12.12.6. Event Monitor 12.12.7. Heart Valve 12.12.8. Pacemaker 12.12.9. Others 12.13. Germany Cardiovascular Device Market Forecast, By End User 12.13.1. Cardiac Centers 12.13.2. Hospitals 12.13.3. Ambulatory Surgical Centers 12.14. Germany Cardiovascular Device Market Forecast, By Application 12.14.1. Stroke 12.14.2. Cerebrovascular Heart Disease 12.14.3. Coronary Heart Disease 12.14.4. Sudden Cardiac Arrest 12.14.5. Others 12.15. U.K. Cardiovascular Device Market Forecast, By Device 12.15.1. Electrocardiography (ECG) 12.15.2. Stent 12.15.3. Defibrillator 12.15.4. Cardiac Catheter 12.15.5. Guide wire 12.15.6. Event Monitor 12.15.7. Heart Valve 12.15.8. Pacemaker 12.15.9. Others 12.16. U.K. Cardiovascular Device Market Forecast, By End User 12.16.1. Cardiac Centers 12.16.2. Hospitals 12.16.3. Ambulatory Surgical Centers 12.17. U.K. Cardiovascular Device Market Forecast, By Application 12.17.1. Stroke 12.17.2. Cerebrovascular Heart Disease 12.17.3. Coronary Heart Disease 12.17.4. Sudden Cardiac Arrest 12.17.5. Others 12.18. France Cardiovascular Device Market Forecast, By Device 12.18.1. Electrocardiography (ECG) 12.18.2. Stent 12.18.3. Defibrillator 12.18.4. Cardiac Catheter 12.18.5. Guide wire 12.18.6. Event Monitor 12.18.7. Heart Valve 12.18.8. Pacemaker 12.18.9. Others 12.19. France Cardiovascular Device Market Forecast, By End User 12.19.1. Cardiac Centers 12.19.2. Hospitals 12.19.3. Ambulatory Surgical Centers 12.20. France Cardiovascular Device Market Forecast, By Application 12.20.1. Stroke 12.20.2. Cerebrovascular Heart Disease 12.20.3. Coronary Heart Disease 12.20.4. Sudden Cardiac Arrest 12.20.5. Others 12.21. Italy Cardiovascular Device Market Forecast, By Device 12.21.1. Electrocardiography (ECG) 12.21.2. Stent 12.21.3. Defibrillator 12.21.4. Cardiac Catheter 12.21.5. Guide wire 12.21.6. Event Monitor 12.21.7. Heart Valve 12.21.8. Pacemaker 12.21.9. Others 12.22. Italy Cardiovascular Device Market Forecast, By End User 12.22.1. Cardiac Centers 12.22.2. Hospitals 12.22.3. Ambulatory Surgical Centers 12.23. Italy Cardiovascular Device Market Forecast, By Application 12.23.1. Stroke 12.23.2. Cerebrovascular Heart Disease 12.23.3. Coronary Heart Disease 12.23.4. Sudden Cardiac Arrest 12.23.5. Others 12.24. Spain Cardiovascular Device Market Forecast, By Device 12.24.1. Electrocardiography (ECG) 12.24.2. Stent 12.24.3. Defibrillator 12.24.4. Cardiac Catheter 12.24.5. Guide wire 12.24.6. Event Monitor 12.24.7. Heart Valve 12.24.8. Pacemaker 12.24.9. Others 12.25. Spain Cardiovascular Device Market Forecast, By End User 12.25.1. Cardiac Centers 12.25.2. Hospitals 12.25.3. Ambulatory Surgical Centers 12.26. Spain Cardiovascular Device Market Forecast, By Application 12.26.1. Stroke 12.26.2. Cerebrovascular Heart Disease 12.26.3. Coronary Heart Disease 12.26.4. Sudden Cardiac Arrest 12.26.5. Others 12.27. Rest of Europe Cardiovascular Device Market Forecast, By Device 12.27.1. Electrocardiography (ECG) 12.27.2. Stent 12.27.3. Defibrillator 12.27.4. Cardiac Catheter 12.27.5. Guide wire 12.27.6. Event Monitor 12.27.7. Heart Valve 12.27.8. Pacemaker 12.27.9. Others 12.28. Rest of Europe Cardiovascular Device Market Forecast, By End User 12.28.1. Cardiac Centers 12.28.2. Hospitals 12.28.3. Ambulatory Surgical Centers 12.29. Rest Of Europe Cardiovascular Device Market Forecast, By Application 12.29.1. Stroke 12.29.2. Cerebrovascular Heart Disease 12.29.3. Coronary Heart Disease 12.29.4. Sudden Cardiac Arrest 12.29.5. Others 12.30. Europe Cardiovascular Device Market Attractiveness Analysis 12.30.1. By Device 12.30.2. By End User 12.30.3. By Application 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Developments 13. Asia Pacific Cardiovascular Device Market Analysis 13.1. Key Findings 13.2. Asia Pacific Cardiovascular Device Market Overview 13.3. Asia Pacific Cardiovascular Device Market Value Share Analysis, By Device 13.4. Asia Pacific Cardiovascular Device Market Forecast, By Device 13.4.1. Electrocardiography (ECG) 13.4.2. Stent 13.4.3. Defibrillator 13.4.4. Cardiac Catheter 13.4.5. Guide wire 13.4.6. Event Monitor 13.4.7. Heart Valve 13.4.8. Pacemaker 13.4.9. Others 13.5. Asia Pacific Cardiovascular Device Market Value Share Analysis, By End User 13.6. Asia Pacific Cardiovascular Device Market Forecast, By End User 13.6.1. Cardiac Centers 13.6.2. Hospitals 13.6.3. Ambulatory Surgical Centers 13.7. Asia Pacific Cardiovascular Device Market Value Share Analysis, By Application 13.8. Asia Pacific Cardiovascular Device Market Forecast, By Application 13.8.1. Stroke 13.8.2. Cerebrovascular Heart Disease 13.8.3. Coronary Heart Disease 13.8.4. Sudden Cardiac Arrest 13.8.5. Others 13.9. Asia Pacific Cardiovascular Device Market Value Share Analysis, by Country 13.10. Asia Pacific Cardiovascular Device Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Cardiovascular Device Market Analysis, by Country 13.12. China Cardiovascular Device Market Forecast, By Device 13.12.1. Electrocardiography (ECG) 13.12.2. Stent 13.12.3. Defibrillator 13.12.4. Cardiac Catheter 13.12.5. Guide wire 13.12.6. Event Monitor 13.12.7. Heart Valve 13.12.8. Pacemaker 13.12.9. Others 13.13. China Cardiovascular Device Market Forecast, By End User 13.13.1. Cardiac Centers 13.13.2. Hospitals 13.13.3. Ambulatory Surgical Centers 13.14. China Cardiovascular Device Market Forecast, By Application 13.14.1. Stroke 13.14.2. Cerebrovascular Heart Disease 13.14.3. Coronary Heart Disease 13.14.4. Sudden Cardiac Arrest 13.14.5. Others 13.15. India Cardiovascular Device Market Forecast, By Device 13.15.1. Electrocardiography (ECG) 13.15.2. Stent 13.15.3. Defibrillator 13.15.4. Cardiac Catheter 13.15.5. Guide wire 13.15.6. Event Monitor 13.15.7. Heart Valve 13.15.8. Pacemaker 13.15.9. Others 13.16. India Cardiovascular Device Market Forecast, By End User 13.16.1. Cardiac Centers 13.16.2. Hospitals 13.16.3. Ambulatory Surgical Centers 13.17. India Cardiovascular Device Market Forecast, By Application 13.17.1. Stroke 13.17.2. Cerebrovascular Heart Disease 13.17.3. Coronary Heart Disease 13.17.4. Sudden Cardiac Arrest 13.17.5. Others 13.18. Japan Cardiovascular Device Market Forecast, By Device 13.18.1. Electrocardiography (ECG) 13.18.2. Stent 13.18.3. Defibrillator 13.18.4. Cardiac Catheter 13.18.5. Guide wire 13.18.6. Event Monitor 13.18.7. Heart Valve 13.18.8. Pacemaker 13.18.9. Others 13.19. Japan Cardiovascular Device Market Forecast, By End User 13.19.1. Cardiac Centers 13.19.2. Hospitals 13.19.3. Ambulatory Surgical Centers 13.20. Japan Cardiovascular Device Market Forecast, By Application 13.20.1. Stroke 13.20.2. Cerebrovascular Heart Disease 13.20.3. Coronary Heart Disease 13.20.4. Sudden Cardiac Arrest 13.20.5. Others 13.21. ASEAN Cardiovascular Device Market Forecast, By Device 13.21.1. Electrocardiography (ECG) 13.21.2. Stent 13.21.3. Defibrillator 13.21.4. Cardiac Catheter 13.21.5. Guide wire 13.21.6. Event Monitor 13.21.7. Heart Valve 13.21.8. Pacemaker 13.21.9. Others 13.22. ASEAN Cardiovascular Device Market Forecast, By End User 13.22.1. Cardiac Centers 13.22.2. Hospitals 13.22.3. Ambulatory Surgical Centers 13.23. ASEAN Cardiovascular Device Market Forecast, By Application 13.23.1. Stroke 13.23.2. Cerebrovascular Heart Disease 13.23.3. Coronary Heart Disease 13.23.4. Sudden Cardiac Arrest 13.23.5. Others 13.24. Rest of Asia Pacific Cardiovascular Device Market Forecast, By Device 13.24.1. Electrocardiography (ECG) 13.24.2. Stent 13.24.3. Defibrillator 13.24.4. Cardiac Catheter 13.24.5. Guide wire 13.24.6. Event Monitor 13.24.7. Heart Valve 13.24.8. Pacemaker 13.24.9. Others 13.25. Rest of Asia Pacific Cardiovascular Device Market Forecast, By End User 13.25.1. Cardiac Centers 13.25.2. Hospitals 13.25.3. Ambulatory Surgical Centers 13.26. Rest of Asia Pacific Cardiovascular Device Market Forecast, By Application 13.26.1. Stroke 13.26.2. Cerebrovascular Heart Disease 13.26.3. Coronary Heart Disease 13.26.4. Sudden Cardiac Arrest 13.26.5. Others 13.27. Asia Pacific Cardiovascular Device Market Attractiveness Analysis 13.27.1. By Device 13.27.2. By End User 13.27.3. By Application 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Developments 14. Middle East & Africa Cardiovascular Device Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Cardiovascular Device Market Overview 14.3. Middle East & Africa Cardiovascular Device Market Value Share Analysis, By Device 14.4. Middle East & Africa Cardiovascular Device Market Forecast, By Device 14.4.1. Electrocardiography (ECG) 14.4.2. Stent 14.4.3. Defibrillator 14.4.4. Cardiac Catheter 14.4.5. Guide wire 14.4.6. Event Monitor 14.4.7. Heart Valve 14.4.8. Pacemaker 14.4.9. Others 14.5. Middle East & Africa Cardiovascular Device Market Value Share Analysis, By End User 14.6. Middle East & Africa Cardiovascular Device Market Forecast, By End User 14.6.1. Cardiac Centers 14.6.2. Hospitals 14.6.3. Ambulatory Surgical Centers 14.7. Middle East & Africa Cardiovascular Device Market Value Share Analysis, By Application 14.8. Middle East & Africa Cardiovascular Device Market Forecast, By Application 14.8.1. Stroke 14.8.2. Cerebrovascular Heart Disease 14.8.3. Coronary Heart Disease 14.8.4. Sudden Cardiac Arrest 14.8.5. Others 14.9. Middle East & Africa Cardiovascular Device Market Value Share Analysis, by Country 14.10. Middle East & Africa Cardiovascular Device Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Cardiovascular Device Market Analysis, by Country 14.12. GCC Cardiovascular Device Market Forecast, By Device 14.12.1. Electrocardiography (ECG) 14.12.2. Stent 14.12.3. Defibrillator 14.12.4. Cardiac Catheter 14.12.5. Guide wire 14.12.6. Event Monitor 14.12.7. Heart Valve 14.12.8. Pacemaker 14.12.9. Others 14.13. GCC Cardiovascular Device Market Forecast, By End User 14.13.1. Cardiac Centers 14.13.2. Hospitals 14.13.3. Ambulatory Surgical Centers 14.14. GCC Cardiovascular Device Market Forecast, By Application 14.14.1. Stroke 14.14.2. Cerebrovascular Heart Disease 14.14.3. Coronary Heart Disease 14.14.4. Sudden Cardiac Arrest 14.14.5. Others 14.15. South Africa Cardiovascular Device Market Forecast, By Device 14.15.1. Electrocardiography (ECG) 14.15.2. Stent 14.15.3. Defibrillator 14.15.4. Cardiac Catheter 14.15.5. Guide wire 14.15.6. Event Monitor 14.15.7. Heart Valve 14.15.8. Pacemaker 14.15.9. Others 14.16. South Africa Cardiovascular Device Market Forecast, By End User 14.16.1. Cardiac Centers 14.16.2. Hospitals 14.16.3. Ambulatory Surgical Centers 14.17. South Africa Cardiovascular Device Market Forecast, By Application 14.17.1. Stroke 14.17.2. Cerebrovascular Heart Disease 14.17.3. Coronary Heart Disease 14.17.4. Sudden Cardiac Arrest 14.17.5. Others 14.18. Rest of Middle East & Africa Cardiovascular Device Market Forecast, By Device 14.18.1. Electrocardiography (ECG) 14.18.2. Stent 14.18.3. Defibrillator 14.18.4. Cardiac Catheter 14.18.5. Guide wire 14.18.6. Event Monitor 14.18.7. Heart Valve 14.18.8. Pacemaker 14.18.9. Others 14.19. Rest of Middle East & Africa Cardiovascular Device Market Forecast, By End User 14.19.1. Cardiac Centers 14.19.2. Hospitals 14.19.3. Ambulatory Surgical Centers 14.20. Rest of Middle East & Africa Cardiovascular Device Market Forecast, By Application 14.20.1. Stroke 14.20.2. Cerebrovascular Heart Disease 14.20.3. Coronary Heart Disease 14.20.4. Sudden Cardiac Arrest 14.20.5. Others 14.21. Middle East & Africa Cardiovascular Device Market Attractiveness Analysis 14.21.1. By Device 14.21.2. By End User 14.21.3. By Application 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Developments 15. South America Cardiovascular Device Market Analysis 15.1. Key Findings 15.2. South America Cardiovascular Device Market Overview 15.3. South America Cardiovascular Device Market Value Share Analysis, By Device 15.4. South America Cardiovascular Device Market Forecast, By Device 15.4.1. Electrocardiography (ECG) 15.4.2. Stent 15.4.3. Defibrillator 15.4.4. Cardiac Catheter 15.4.5. Guide wire 15.4.6. Event Monitor 15.4.7. Heart Valve 15.4.8. Pacemaker 15.4.9. Others 15.5. South America Cardiovascular Device Market Value Share Analysis, By End User 15.6. South America Cardiovascular Device Market Forecast, By End User 15.6.1. Cardiac Centers 15.6.2. Hospitals 15.6.3. Ambulatory Surgical Centers 15.7. South America Cardiovascular Device Market Value Share Analysis, By Application 15.8. South America Cardiovascular Device Market Forecast, By Application 15.8.1. Stroke 15.8.2. Cerebrovascular Heart Disease 15.8.3. Coronary Heart Disease 15.8.4. Sudden Cardiac Arrest 15.8.5. Others 15.9. South America Cardiovascular Device Market Value Share Analysis, by Country 15.10. South America Cardiovascular Device Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Cardiovascular Device Market Analysis, by Country 15.12. Brazil Cardiovascular Device Market Forecast, By Device 15.12.1. Electrocardiography (ECG) 15.12.2. Stent 15.12.3. Defibrillator 15.12.4. Cardiac Catheter 15.12.5. Guide wire 15.12.6. Event Monitor 15.12.7. Heart Valve 15.12.8. Pacemaker 15.12.9. Others 15.13. Brazil Cardiovascular Device Market Forecast, By End User 15.13.1. Cardiac Centers 15.13.2. Hospitals 15.13.3. Ambulatory Surgical Centers 15.14. Brazil Cardiovascular Device Market Forecast, By Application 15.14.1. Stroke 15.14.2. Cerebrovascular Heart Disease 15.14.3. Coronary Heart Disease 15.14.4. Sudden Cardiac Arrest 15.14.5. Others 15.15. Mexico Cardiovascular Device Market Forecast, By Device 15.15.1. Electrocardiography (ECG) 15.15.2. Stent 15.15.3. Defibrillator 15.15.4. Cardiac Catheter 15.15.5. Guide wire 15.15.6. Event Monitor 15.15.7. Heart Valve 15.15.8. Pacemaker 15.15.9. Others 15.16. Mexico Cardiovascular Device Market Forecast, By End User 15.16.1. Cardiac Centers 15.16.2. Hospitals 15.16.3. Ambulatory Surgical Centers 15.17. Mexico Cardiovascular Device Market Forecast, By Application 15.17.1. Stroke 15.17.2. Cerebrovascular Heart Disease 15.17.3. Coronary Heart Disease 15.17.4. Sudden Cardiac Arrest 15.17.5. Others 15.18. Rest of South America Cardiovascular Device Market Forecast, By Device 15.18.1. Electrocardiography (ECG) 15.18.2. Stent 15.18.3. Defibrillator 15.18.4. Cardiac Catheter 15.18.5. Guide wire 15.18.6. Event Monitor 15.18.7. Heart Valve 15.18.8. Pacemaker 15.18.9. Others 15.19. Rest of South America Cardiovascular Device Market Forecast, By End User 15.19.1. Cardiac Centers 15.19.2. Hospitals 15.19.3. Ambulatory Surgical Centers 15.20. Rest of South America Cardiovascular Device Market Forecast, By Application 15.20.1. Stroke 15.20.2. Cerebrovascular Heart Disease 15.20.3. Coronary Heart Disease 15.20.4. Sudden Cardiac Arrest 15.20.5. Others 15.21. South America Cardiovascular Device Market Attractiveness Analysis 15.21.1. By Device 15.21.2. By End User 15.21.3. By Application 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Abbott 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Development Footprint 16.3.2. Attana AB 16.3.3. Agilent Technologies, Inc. 16.3.4. Danaher Corporation 16.3.5. F. Hoffmann-La Roche AG 16.3.6. Bio-Rad Laboratories 16.3.7. GWC Technologies 16.3.8. PerkinElmer, Inc. 16.3.9. BiOptix, Inc. 16.3.10. Siemens AG 16.3.11. BD 16.3.12. B. Braun Melsungen AG 16.3.13. Edwards Lifesciences Corporation 16.3.14. Medtronic 16.3.15. Biosense Webster, Inc (Johnson and Johnson) 16.3.16. General Electric Company 16.3.17. Koninklijke Philips N.V 16.3.18. Boston Scientific Corporation 16.3.19. Jarvik Heart 16.3.20. Maquet Cardiovascular 16.3.21. Merit Medical Systems 16.3.22. On-X Life Technologies 16.3.23. Orbusneich 16.3.24. St. Jude Medical 16.3.25. Sorin Group 16.3.26. Spectranetics 16.3.27. Sunshine Heart 16.3.28. Syncardia Systems 16.3.29. Thoratec 16.3.30. Volcano 17. Primary Key Insights

About This Report

Report ID 60060
Category Healthcare
Published Date Oct 2022
Updated Date